SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001193125-20-035546
Filing Date
2020-02-13
Accepted
2020-02-13 16:08:05
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d850894dsc13ga.htm SC 13G/A 33069
  Complete submission text file 0001193125-20-035546.txt   34452
Mailing Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 457-2700
Allogene Therapeutics, Inc. (Subject) CIK: 0001737287 (see all company filings)

IRS No.: 823562771 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90685 | Film No.: 20610505
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 811 STRADA VECCHIA LOS ANGELES CA 90077
Business Address 811 STRADA VECCHIA LOS ANGELES CA 90077 650-457-2700
Seaview Trust (Filed by) CIK: 0001767779 (see all company filings)

IRS No.: 000000000
Type: SC 13G/A